ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,245Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 54

$502K Total Retail Price of All Prescriptions

Rank: 14 out of 54

725 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 725 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

3% of this provider’s 725 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 410 409 1 1
FUROSEMIDE 278 277 2 3
LEVOTHYROXINE SODIUM 269 269 3 2
DONEPEZIL HCL 265 265 4 8
AMLODIPINE BESYLATE 265 257 4 4
OMEPRAZOLE 228 227 6 9
SIMVASTATIN 225 223 7 5
METOPROLOL TARTRATE 201 200 8 7
SERTRALINE HCL 185 185 9 12
MIRTAZAPINE 175 174 10 11
NAMENDA 170 170 11 13
ATORVASTATIN CALCIUM 154 152 12 15
LISINOPRIL 144 133 13 6
METOPROLOL SUCCINATE 121 121 14 14
ESCITALOPRAM OXALATE 115 115 15 18
GABAPENTIN 109 109 16 16
FLUTICASONE PROPIONATE 108 106 17 89
HYDROCHLOROTHIAZIDE 103 101 18 20
QUETIAPINE FUMARATE 96 96 19 21
ZOLPIDEM TARTRATE 95 94 20 35
TRAZODONE HCL 93 91 21 10
CITALOPRAM HBR 90 90 22 17
TRAMADOL HCL-ACETAMINOPHEN 81 81 23 136
DIGOXIN 79 79 24 40
PANTOPRAZOLE SODIUM 78 75 25 33
TAMSULOSIN HCL 71 71 26 25
METFORMIN HCL 71 67 26 19
CYMBALTA 68 68 28 26
AZITHROMYCIN 68 63 28 65
DIVALPROEX SODIUM 64 64 30 28
CLOPIDOGREL 62 62 31 38
PREDNISONE 61 56 32 34
DIOVAN 60 60 33 29
ISOSORBIDE MONONITRATE ER 57 57 34 41
ALENDRONATE SODIUM 57 57 34 31
CIPROFLOXACIN HCL 57 56 34 96
OXYCODONE-ACETAMINOPHEN 55 52 S2 37 98
CEPHALEXIN 50 49 38 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.